flubendazole has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khachigian, LM | 1 |
| Chen, C; Ding, Y; Liu, H; Sun, M; Wang, H; Wu, D | 1 |
2 review(s) available for flubendazole and Neoplasms
| Article | Year |
|---|---|
Emerging insights on functions of the anthelmintic flubendazole as a repurposed anticancer agent.
Topics: Antinematodal Agents; Cell Proliferation; Drug Repositioning; Ferroptosis; Humans; Mebendazole; Neoplasms; Neoplastic Stem Cells; Programmed Cell Death 1 Receptor | 2021 |
Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clinical Studies as Topic; Drug Evaluation, Preclinical; Drug Monitoring; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mebendazole; Neoplasms; Organ Specificity; Signal Transduction; Treatment Outcome; Xenograft Model Antitumor Assays | 2022 |